nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—Promazine—Tamoxifen—pancreatic cancer	0.168	1	CrCrCtD
Perphenazine—CYP2B6—Tamoxifen—pancreatic cancer	0.0468	0.0968	CbGbCtD
Perphenazine—CYP2B6—Irinotecan—pancreatic cancer	0.0359	0.0743	CbGbCtD
Perphenazine—CYP2C8—Tamoxifen—pancreatic cancer	0.0354	0.0733	CbGbCtD
Perphenazine—CYP1A2—Dacarbazine—pancreatic cancer	0.0345	0.0713	CbGbCtD
Perphenazine—CYP2C8—Erlotinib—pancreatic cancer	0.0301	0.0623	CbGbCtD
Perphenazine—CYP2C19—Tamoxifen—pancreatic cancer	0.0297	0.0615	CbGbCtD
Perphenazine—CYP1A2—Tamoxifen—pancreatic cancer	0.0274	0.0568	CbGbCtD
Perphenazine—CYP2C8—Fluorouracil—pancreatic cancer	0.0261	0.054	CbGbCtD
Perphenazine—CYP2C9—Tamoxifen—pancreatic cancer	0.0247	0.0511	CbGbCtD
Perphenazine—CYP1A2—Erlotinib—pancreatic cancer	0.0233	0.0483	CbGbCtD
Perphenazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0226	0.0468	CbGbCtD
Perphenazine—CYP1A2—Fluorouracil—pancreatic cancer	0.0202	0.0418	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—pancreatic cancer	0.0196	0.0406	CbGbCtD
Perphenazine—CYP2D6—Erlotinib—pancreatic cancer	0.0192	0.0398	CbGbCtD
Perphenazine—CYP2C9—Fluorouracil—pancreatic cancer	0.0182	0.0377	CbGbCtD
Perphenazine—CYP3A4—Tamoxifen—pancreatic cancer	0.0144	0.0297	CbGbCtD
Perphenazine—CYP3A4—Erlotinib—pancreatic cancer	0.0122	0.0253	CbGbCtD
Perphenazine—HTR7—enteric nervous system—pancreatic cancer	0.0114	0.277	CbGeAlD
Perphenazine—CYP3A4—Irinotecan—pancreatic cancer	0.011	0.0228	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—pancreatic cancer	0.00948	0.0196	CbGbCtD
Perphenazine—CYP3A4—Docetaxel—pancreatic cancer	0.00809	0.0167	CbGbCtD
Perphenazine—CYP3A4—Sunitinib—pancreatic cancer	0.00805	0.0167	CbGbCtD
Perphenazine—HTR2A—enteric nervous system—pancreatic cancer	0.00714	0.173	CbGeAlD
Perphenazine—CYP3A4—Doxorubicin—pancreatic cancer	0.00603	0.0125	CbGbCtD
Perphenazine—AOX1—gall bladder—pancreatic cancer	0.00243	0.0587	CbGeAlD
Perphenazine—CALM2—gall bladder—pancreatic cancer	0.00172	0.0415	CbGeAlD
Perphenazine—AOX1—islet of Langerhans—pancreatic cancer	0.00159	0.0385	CbGeAlD
Perphenazine—CYP2C18—digestive system—pancreatic cancer	0.00151	0.0365	CbGeAlD
Perphenazine—CALM3—islet of Langerhans—pancreatic cancer	0.00143	0.0347	CbGeAlD
Perphenazine—CALM2—islet of Langerhans—pancreatic cancer	0.00113	0.0272	CbGeAlD
Perphenazine—CALM1—islet of Langerhans—pancreatic cancer	0.00112	0.0271	CbGeAlD
Perphenazine—AOX1—pancreas—pancreatic cancer	0.00112	0.027	CbGeAlD
Perphenazine—CALM3—pancreas—pancreatic cancer	0.00101	0.0244	CbGeAlD
Perphenazine—AOX1—digestive system—pancreatic cancer	0.000955	0.0231	CbGeAlD
Perphenazine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000802	0.0194	CbGeAlD
Perphenazine—CALM2—pancreas—pancreatic cancer	0.000791	0.0191	CbGeAlD
Perphenazine—CALM1—pancreas—pancreatic cancer	0.000787	0.019	CbGeAlD
Perphenazine—CALM2—digestive system—pancreatic cancer	0.000675	0.0163	CbGeAlD
Perphenazine—CALM1—digestive system—pancreatic cancer	0.000672	0.0163	CbGeAlD
Perphenazine—HTR7—digestive system—pancreatic cancer	0.000657	0.0159	CbGeAlD
Perphenazine—CYP2C19—digestive system—pancreatic cancer	0.000641	0.0155	CbGeAlD
Perphenazine—ADRA2A—pancreas—pancreatic cancer	0.000564	0.0136	CbGeAlD
Perphenazine—CYP1A2—digestive system—pancreatic cancer	0.000524	0.0127	CbGeAlD
Perphenazine—CYP2B6—digestive system—pancreatic cancer	0.000502	0.0121	CbGeAlD
Perphenazine—CYP2C9—digestive system—pancreatic cancer	0.000497	0.012	CbGeAlD
Perphenazine—HRH1—digestive system—pancreatic cancer	0.00049	0.0119	CbGeAlD
Perphenazine—HTR2A—digestive system—pancreatic cancer	0.00041	0.00991	CbGeAlD
Perphenazine—Abnormal dreams—Epirubicin—pancreatic cancer	0.000408	0.00283	CcSEcCtD
Perphenazine—Convulsion—Sunitinib—pancreatic cancer	0.000407	0.00282	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000406	0.00282	CcSEcCtD
Perphenazine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000405	0.00281	CcSEcCtD
Perphenazine—Hypertension—Sunitinib—pancreatic cancer	0.000405	0.00281	CcSEcCtD
Perphenazine—Insomnia—Tamoxifen—pancreatic cancer	0.000404	0.00281	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—pancreatic cancer	0.000403	0.0028	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.0004	0.00278	CcSEcCtD
Perphenazine—Insomnia—Erlotinib—pancreatic cancer	0.0004	0.00278	CcSEcCtD
Perphenazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000399	0.00277	CcSEcCtD
Perphenazine—Dyspnoea—Erlotinib—pancreatic cancer	0.000394	0.00274	CcSEcCtD
Perphenazine—Dry mouth—Sunitinib—pancreatic cancer	0.000391	0.00271	CcSEcCtD
Perphenazine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000389	0.0027	CcSEcCtD
Perphenazine—Decreased appetite—Erlotinib—pancreatic cancer	0.000385	0.00267	CcSEcCtD
Perphenazine—Dysphagia—Docetaxel—pancreatic cancer	0.000384	0.00266	CcSEcCtD
Perphenazine—Pain—Tamoxifen—pancreatic cancer	0.000382	0.00265	CcSEcCtD
Perphenazine—Constipation—Tamoxifen—pancreatic cancer	0.000382	0.00265	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000382	0.00265	CcSEcCtD
Perphenazine—Infection—Sunitinib—pancreatic cancer	0.000381	0.00264	CcSEcCtD
Perphenazine—CYP3A4—digestive system—pancreatic cancer	0.000379	0.00917	CbGeAlD
Perphenazine—Constipation—Erlotinib—pancreatic cancer	0.000378	0.00263	CcSEcCtD
Perphenazine—Pain—Erlotinib—pancreatic cancer	0.000378	0.00263	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000377	0.00262	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—pancreatic cancer	0.000377	0.00262	CcSEcCtD
Perphenazine—Shock—Sunitinib—pancreatic cancer	0.000377	0.00261	CcSEcCtD
Perphenazine—Erythema—Gemcitabine—pancreatic cancer	0.000377	0.00261	CcSEcCtD
Perphenazine—CYP2D6—digestive system—pancreatic cancer	0.000373	0.00903	CbGeAlD
Perphenazine—Muscle spasms—Irinotecan—pancreatic cancer	0.000372	0.00258	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000371	0.00257	CcSEcCtD
Perphenazine—Erythema—Fluorouracil—pancreatic cancer	0.00037	0.00257	CcSEcCtD
Perphenazine—Anorexia—Sunitinib—pancreatic cancer	0.000365	0.00253	CcSEcCtD
Perphenazine—Pancytopenia—Docetaxel—pancreatic cancer	0.000364	0.00253	CcSEcCtD
Perphenazine—Urticaria—Tamoxifen—pancreatic cancer	0.000355	0.00247	CcSEcCtD
Perphenazine—Body temperature increased—Erlotinib—pancreatic cancer	0.00035	0.00243	CcSEcCtD
Perphenazine—Vision blurred—Fluorouracil—pancreatic cancer	0.000349	0.00242	CcSEcCtD
Perphenazine—Syncope—Irinotecan—pancreatic cancer	0.000347	0.00241	CcSEcCtD
Perphenazine—Insomnia—Sunitinib—pancreatic cancer	0.000346	0.0024	CcSEcCtD
Perphenazine—Leukopenia—Irinotecan—pancreatic cancer	0.000346	0.0024	CcSEcCtD
Perphenazine—Dyspnoea—Sunitinib—pancreatic cancer	0.000341	0.00237	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000341	0.00237	CcSEcCtD
Perphenazine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00034	0.00236	CcSEcCtD
Perphenazine—Cough—Irinotecan—pancreatic cancer	0.000337	0.00234	CcSEcCtD
Perphenazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000337	0.00234	CcSEcCtD
Perphenazine—Hypertension—Irinotecan—pancreatic cancer	0.000334	0.00232	CcSEcCtD
Perphenazine—Jaundice—Docetaxel—pancreatic cancer	0.000333	0.00231	CcSEcCtD
Perphenazine—Eczema—Epirubicin—pancreatic cancer	0.000333	0.00231	CcSEcCtD
Perphenazine—Decreased appetite—Sunitinib—pancreatic cancer	0.000333	0.00231	CcSEcCtD
Perphenazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000331	0.0023	CcSEcCtD
Perphenazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000329	0.00229	CcSEcCtD
Perphenazine—Cough—Gemcitabine—pancreatic cancer	0.000329	0.00228	CcSEcCtD
Perphenazine—Pain—Sunitinib—pancreatic cancer	0.000328	0.00227	CcSEcCtD
Perphenazine—Constipation—Sunitinib—pancreatic cancer	0.000328	0.00227	CcSEcCtD
Perphenazine—Hypertension—Gemcitabine—pancreatic cancer	0.000325	0.00226	CcSEcCtD
Perphenazine—Convulsion—Fluorouracil—pancreatic cancer	0.000321	0.00223	CcSEcCtD
Perphenazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000319	0.00221	CcSEcCtD
Perphenazine—Confusional state—Irinotecan—pancreatic cancer	0.000318	0.00221	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000317	0.0022	CcSEcCtD
Perphenazine—Pruritus—Tamoxifen—pancreatic cancer	0.000316	0.0022	CcSEcCtD
Perphenazine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000316	0.00219	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000315	0.00219	CcSEcCtD
Perphenazine—Infection—Irinotecan—pancreatic cancer	0.000313	0.00218	CcSEcCtD
Perphenazine—Pruritus—Erlotinib—pancreatic cancer	0.000313	0.00217	CcSEcCtD
Perphenazine—Shock—Irinotecan—pancreatic cancer	0.00031	0.00215	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000309	0.00215	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—pancreatic cancer	0.000308	0.00214	CcSEcCtD
Perphenazine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000307	0.00213	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000307	0.00213	CcSEcCtD
Perphenazine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000306	0.00212	CcSEcCtD
Perphenazine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000305	0.00212	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—pancreatic cancer	0.000305	0.00212	CcSEcCtD
Perphenazine—Infection—Gemcitabine—pancreatic cancer	0.000305	0.00212	CcSEcCtD
Perphenazine—Confusional state—Fluorouracil—pancreatic cancer	0.000305	0.00211	CcSEcCtD
Perphenazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000303	0.0021	CcSEcCtD
Perphenazine—Diarrhoea—Erlotinib—pancreatic cancer	0.000303	0.0021	CcSEcCtD
Perphenazine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000302	0.0021	CcSEcCtD
Perphenazine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000302	0.0021	CcSEcCtD
Perphenazine—Anorexia—Irinotecan—pancreatic cancer	0.000301	0.00209	CcSEcCtD
Perphenazine—Infection—Fluorouracil—pancreatic cancer	0.0003	0.00208	CcSEcCtD
Perphenazine—Dizziness—Tamoxifen—pancreatic cancer	0.000296	0.00205	CcSEcCtD
Perphenazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000295	0.00205	CcSEcCtD
Perphenazine—Hypotension—Irinotecan—pancreatic cancer	0.000295	0.00205	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000294	0.00204	CcSEcCtD
Perphenazine—Anorexia—Gemcitabine—pancreatic cancer	0.000293	0.00203	CcSEcCtD
Perphenazine—Dizziness—Erlotinib—pancreatic cancer	0.000293	0.00203	CcSEcCtD
Perphenazine—Anorexia—Fluorouracil—pancreatic cancer	0.000288	0.002	CcSEcCtD
Perphenazine—Hypotension—Gemcitabine—pancreatic cancer	0.000287	0.00199	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000286	0.00199	CcSEcCtD
Perphenazine—Insomnia—Irinotecan—pancreatic cancer	0.000285	0.00198	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000285	0.00197	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000284	0.00197	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—pancreatic cancer	0.000283	0.00196	CcSEcCtD
Perphenazine—Hypotension—Fluorouracil—pancreatic cancer	0.000282	0.00196	CcSEcCtD
Perphenazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000282	0.00196	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—pancreatic cancer	0.000281	0.00195	CcSEcCtD
Perphenazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000281	0.00195	CcSEcCtD
Perphenazine—Somnolence—Irinotecan—pancreatic cancer	0.00028	0.00195	CcSEcCtD
Perphenazine—Headache—Tamoxifen—pancreatic cancer	0.00028	0.00194	CcSEcCtD
Perphenazine—Insomnia—Gemcitabine—pancreatic cancer	0.000278	0.00193	CcSEcCtD
Perphenazine—Headache—Erlotinib—pancreatic cancer	0.000277	0.00192	CcSEcCtD
Perphenazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000274	0.0019	CcSEcCtD
Perphenazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000274	0.0019	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000273	0.0019	CcSEcCtD
Perphenazine—Insomnia—Fluorouracil—pancreatic cancer	0.000273	0.0019	CcSEcCtD
Perphenazine—Somnolence—Gemcitabine—pancreatic cancer	0.000273	0.0019	CcSEcCtD
Perphenazine—Pruritus—Sunitinib—pancreatic cancer	0.000271	0.00188	CcSEcCtD
Perphenazine—Pain—Irinotecan—pancreatic cancer	0.00027	0.00187	CcSEcCtD
Perphenazine—Constipation—Irinotecan—pancreatic cancer	0.00027	0.00187	CcSEcCtD
Perphenazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000269	0.00187	CcSEcCtD
Perphenazine—Somnolence—Fluorouracil—pancreatic cancer	0.000269	0.00186	CcSEcCtD
Perphenazine—Erythema—Docetaxel—pancreatic cancer	0.000267	0.00185	CcSEcCtD
Perphenazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000267	0.00185	CcSEcCtD
Perphenazine—Muscular weakness—Epirubicin—pancreatic cancer	0.000264	0.00183	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000263	0.00183	CcSEcCtD
Perphenazine—Constipation—Gemcitabine—pancreatic cancer	0.000263	0.00182	CcSEcCtD
Perphenazine—Pain—Gemcitabine—pancreatic cancer	0.000263	0.00182	CcSEcCtD
Perphenazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000263	0.00182	CcSEcCtD
Perphenazine—Diarrhoea—Sunitinib—pancreatic cancer	0.000262	0.00182	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—pancreatic cancer	0.00026	0.00181	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—pancreatic cancer	0.000259	0.0018	CcSEcCtD
Perphenazine—Asthma—Epirubicin—pancreatic cancer	0.000259	0.0018	CcSEcCtD
Perphenazine—Pain—Fluorouracil—pancreatic cancer	0.000258	0.00179	CcSEcCtD
Perphenazine—Muscle spasms—Docetaxel—pancreatic cancer	0.000257	0.00178	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—pancreatic cancer	0.000256	0.00178	CcSEcCtD
Perphenazine—Dizziness—Sunitinib—pancreatic cancer	0.000253	0.00176	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000253	0.00176	CcSEcCtD
Perphenazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000249	0.00173	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000246	0.0017	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000244	0.00169	CcSEcCtD
Perphenazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000243	0.00169	CcSEcCtD
Perphenazine—Urticaria—Fluorouracil—pancreatic cancer	0.00024	0.00167	CcSEcCtD
Perphenazine—Headache—Sunitinib—pancreatic cancer	0.00024	0.00167	CcSEcCtD
Perphenazine—Syncope—Docetaxel—pancreatic cancer	0.00024	0.00166	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—pancreatic cancer	0.000239	0.00166	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—pancreatic cancer	0.000239	0.00166	CcSEcCtD
Perphenazine—Leukopenia—Docetaxel—pancreatic cancer	0.000239	0.00166	CcSEcCtD
Perphenazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000239	0.00166	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000237	0.00164	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000236	0.00164	CcSEcCtD
Perphenazine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000235	0.00163	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000233	0.00162	CcSEcCtD
Perphenazine—Cough—Docetaxel—pancreatic cancer	0.000233	0.00162	CcSEcCtD
Perphenazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000232	0.00161	CcSEcCtD
Perphenazine—Convulsion—Docetaxel—pancreatic cancer	0.000232	0.00161	CcSEcCtD
Perphenazine—Hypertension—Docetaxel—pancreatic cancer	0.000231	0.0016	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—pancreatic cancer	0.000231	0.0016	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000227	0.00158	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—pancreatic cancer	0.000225	0.00156	CcSEcCtD
Perphenazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000223	0.00154	CcSEcCtD
Perphenazine—Dry mouth—Docetaxel—pancreatic cancer	0.000223	0.00154	CcSEcCtD
Perphenazine—Confusional state—Docetaxel—pancreatic cancer	0.00022	0.00153	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000218	0.00152	CcSEcCtD
Perphenazine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000218	0.00151	CcSEcCtD
Perphenazine—Pruritus—Gemcitabine—pancreatic cancer	0.000217	0.00151	CcSEcCtD
Perphenazine—Infection—Docetaxel—pancreatic cancer	0.000217	0.0015	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000216	0.0015	CcSEcCtD
Perphenazine—Diarrhoea—Irinotecan—pancreatic cancer	0.000216	0.0015	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000215	0.00149	CcSEcCtD
Perphenazine—Shock—Docetaxel—pancreatic cancer	0.000215	0.00149	CcSEcCtD
Perphenazine—Pruritus—Fluorouracil—pancreatic cancer	0.000214	0.00148	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000213	0.00148	CcSEcCtD
Perphenazine—Tachycardia—Docetaxel—pancreatic cancer	0.000213	0.00148	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—pancreatic cancer	0.000211	0.00146	CcSEcCtD
Perphenazine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00021	0.00146	CcSEcCtD
Perphenazine—Dizziness—Irinotecan—pancreatic cancer	0.000209	0.00145	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—pancreatic cancer	0.000208	0.00144	CcSEcCtD
Perphenazine—Anorexia—Docetaxel—pancreatic cancer	0.000208	0.00144	CcSEcCtD
Perphenazine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000207	0.00143	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000206	0.00143	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000204	0.00142	CcSEcCtD
Perphenazine—Hypotension—Docetaxel—pancreatic cancer	0.000204	0.00141	CcSEcCtD
Perphenazine—Dizziness—Fluorouracil—pancreatic cancer	0.0002	0.00139	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000199	0.00138	CcSEcCtD
Perphenazine—Headache—Irinotecan—pancreatic cancer	0.000198	0.00137	CcSEcCtD
Perphenazine—Insomnia—Docetaxel—pancreatic cancer	0.000197	0.00137	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—pancreatic cancer	0.000195	0.00135	CcSEcCtD
Perphenazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000194	0.00135	CcSEcCtD
Perphenazine—Somnolence—Docetaxel—pancreatic cancer	0.000194	0.00135	CcSEcCtD
Perphenazine—Headache—Gemcitabine—pancreatic cancer	0.000193	0.00134	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000191	0.00132	CcSEcCtD
Perphenazine—Decreased appetite—Docetaxel—pancreatic cancer	0.00019	0.00132	CcSEcCtD
Perphenazine—Headache—Fluorouracil—pancreatic cancer	0.000189	0.00131	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000189	0.00131	CcSEcCtD
Perphenazine—Constipation—Docetaxel—pancreatic cancer	0.000187	0.00129	CcSEcCtD
Perphenazine—Pain—Docetaxel—pancreatic cancer	0.000187	0.00129	CcSEcCtD
Perphenazine—Erythema—Epirubicin—pancreatic cancer	0.00018	0.00125	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000173	0.0012	CcSEcCtD
Perphenazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000172	0.0012	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—pancreatic cancer	0.00017	0.00118	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—pancreatic cancer	0.000167	0.00116	CcSEcCtD
Perphenazine—Agitation—Epirubicin—pancreatic cancer	0.000166	0.00115	CcSEcCtD
Perphenazine—Syncope—Epirubicin—pancreatic cancer	0.000162	0.00112	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—pancreatic cancer	0.000161	0.00112	CcSEcCtD
Perphenazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000161	0.00112	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.00016	0.00111	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000158	0.0011	CcSEcCtD
Perphenazine—Cough—Epirubicin—pancreatic cancer	0.000157	0.00109	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000157	0.00109	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—pancreatic cancer	0.000156	0.00108	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—pancreatic cancer	0.000156	0.00108	CcSEcCtD
Perphenazine—Pruritus—Docetaxel—pancreatic cancer	0.000154	0.00107	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—pancreatic cancer	0.000153	0.00106	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—pancreatic cancer	0.00015	0.00104	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—pancreatic cancer	0.00015	0.00104	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000149	0.00104	CcSEcCtD
Perphenazine—Diarrhoea—Docetaxel—pancreatic cancer	0.000149	0.00104	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—pancreatic cancer	0.000148	0.00103	CcSEcCtD
Perphenazine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000147	0.00102	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000147	0.00102	CcSEcCtD
Perphenazine—Infection—Epirubicin—pancreatic cancer	0.000146	0.00101	CcSEcCtD
Perphenazine—Cough—Doxorubicin—pancreatic cancer	0.000146	0.00101	CcSEcCtD
Perphenazine—Shock—Epirubicin—pancreatic cancer	0.000145	0.001	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—pancreatic cancer	0.000145	0.001	CcSEcCtD
Perphenazine—Dizziness—Docetaxel—pancreatic cancer	0.000144	0.001	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—pancreatic cancer	0.000144	0.000999	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—pancreatic cancer	0.000144	0.000996	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—pancreatic cancer	0.00014	0.000973	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000139	0.000964	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—pancreatic cancer	0.000137	0.000954	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—pancreatic cancer	0.000137	0.000952	CcSEcCtD
Perphenazine—Headache—Docetaxel—pancreatic cancer	0.000137	0.000948	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000136	0.000945	CcSEcCtD
Perphenazine—Infection—Doxorubicin—pancreatic cancer	0.000135	0.000938	CcSEcCtD
Perphenazine—Shock—Doxorubicin—pancreatic cancer	0.000134	0.000929	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—pancreatic cancer	0.000133	0.000923	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—pancreatic cancer	0.000133	0.000922	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000131	0.00091	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—pancreatic cancer	0.000131	0.000908	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—pancreatic cancer	0.00013	0.0009	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—pancreatic cancer	0.000128	0.000887	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—pancreatic cancer	0.000127	0.000883	CcSEcCtD
Perphenazine—Pain—Epirubicin—pancreatic cancer	0.000126	0.000873	CcSEcCtD
Perphenazine—Constipation—Epirubicin—pancreatic cancer	0.000126	0.000873	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—pancreatic cancer	0.000123	0.000854	CcSEcCtD
Perphenazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000121	0.000842	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—pancreatic cancer	0.000121	0.00084	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000118	0.000821	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—pancreatic cancer	0.000117	0.000811	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—pancreatic cancer	0.000116	0.000808	CcSEcCtD
Perphenazine—Pain—Doxorubicin—pancreatic cancer	0.000116	0.000808	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000116	0.000807	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000108	0.000752	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—pancreatic cancer	0.000108	0.00075	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000108	0.000747	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—pancreatic cancer	0.000104	0.000722	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—pancreatic cancer	0.000101	0.000698	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.0001	0.000696	CcSEcCtD
Perphenazine—Dizziness—Epirubicin—pancreatic cancer	9.73e-05	0.000675	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—pancreatic cancer	9.63e-05	0.000668	CcSEcCtD
Perphenazine—Diarrhoea—Doxorubicin—pancreatic cancer	9.31e-05	0.000646	CcSEcCtD
Perphenazine—Headache—Epirubicin—pancreatic cancer	9.22e-05	0.00064	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—pancreatic cancer	9e-05	0.000625	CcSEcCtD
Perphenazine—Headache—Doxorubicin—pancreatic cancer	8.53e-05	0.000592	CcSEcCtD
Perphenazine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.3e-06	3.24e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—NRAS—pancreatic cancer	5.3e-06	3.24e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—NRAS—pancreatic cancer	5.3e-06	3.24e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	5.3e-06	3.24e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	5.29e-06	3.23e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTEN—pancreatic cancer	5.28e-06	3.23e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	5.28e-06	3.23e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	5.27e-06	3.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	5.24e-06	3.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—EGFR—pancreatic cancer	5.23e-06	3.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—EGFR—pancreatic cancer	5.23e-06	3.2e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	5.21e-06	3.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	5.21e-06	3.19e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—pancreatic cancer	5.21e-06	3.19e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	5.2e-06	3.18e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	5.18e-06	3.17e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.18e-06	3.17e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	5.17e-06	3.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTEN—pancreatic cancer	5.14e-06	3.15e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	5.14e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	5.14e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.13e-06	3.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—pancreatic cancer	5.11e-06	3.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—pancreatic cancer	5.1e-06	3.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—pancreatic cancer	5.09e-06	3.11e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.06e-06	3.1e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	5.05e-06	3.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	5.04e-06	3.09e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.02e-06	3.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—EGFR—pancreatic cancer	4.99e-06	3.05e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	4.98e-06	3.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.98e-06	3.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—pancreatic cancer	4.98e-06	3.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—pancreatic cancer	4.98e-06	3.04e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	4.97e-06	3.04e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.97e-06	3.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.97e-06	3.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	4.96e-06	3.03e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	4.95e-06	3.03e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—TYMS—pancreatic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—pancreatic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—pancreatic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—pancreatic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—pancreatic cancer	4.94e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.93e-06	3.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—pancreatic cancer	4.93e-06	3.01e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—pancreatic cancer	4.93e-06	3.01e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	4.92e-06	3.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	4.88e-06	2.99e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	4.88e-06	2.99e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.88e-06	2.98e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	4.87e-06	2.98e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	4.85e-06	2.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	4.84e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	4.83e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—EGFR—pancreatic cancer	4.83e-06	2.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—EGFR—pancreatic cancer	4.83e-06	2.95e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.81e-06	2.95e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.81e-06	2.95e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	4.8e-06	2.94e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	4.79e-06	2.93e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	4.78e-06	2.93e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	4.76e-06	2.91e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	4.76e-06	2.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	4.75e-06	2.91e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	4.74e-06	2.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—pancreatic cancer	4.72e-06	2.88e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	4.71e-06	2.88e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	4.71e-06	2.88e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.7e-06	2.87e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	4.7e-06	2.87e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—pancreatic cancer	4.69e-06	2.87e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	4.68e-06	2.86e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	4.67e-06	2.86e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	4.67e-06	2.86e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	4.66e-06	2.85e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	4.63e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	4.63e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	4.63e-06	2.83e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	4.62e-06	2.83e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	4.62e-06	2.83e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.62e-06	2.83e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	4.61e-06	2.82e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	4.6e-06	2.82e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	4.6e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	4.6e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	4.6e-06	2.81e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	4.58e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.58e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	4.58e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—pancreatic cancer	4.56e-06	2.79e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—pancreatic cancer	4.56e-06	2.79e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	4.55e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—pancreatic cancer	4.54e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—pancreatic cancer	4.54e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.54e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—pancreatic cancer	4.47e-06	2.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	4.46e-06	2.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	4.43e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	4.43e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	4.41e-06	2.7e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	4.38e-06	2.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	4.37e-06	2.67e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	4.37e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—pancreatic cancer	4.34e-06	2.66e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—pancreatic cancer	4.33e-06	2.65e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	4.33e-06	2.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	4.31e-06	2.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	4.31e-06	2.64e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	4.31e-06	2.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	4.3e-06	2.63e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	4.29e-06	2.62e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	4.28e-06	2.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.27e-06	2.61e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.27e-06	2.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	4.26e-06	2.6e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.25e-06	2.6e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.23e-06	2.59e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	4.22e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.21e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.21e-06	2.58e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.21e-06	2.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.21e-06	2.57e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.21e-06	2.57e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—pancreatic cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—pancreatic cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	4.2e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—pancreatic cancer	4.19e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—pancreatic cancer	4.19e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	4.18e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.18e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	4.16e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	4.16e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.13e-06	2.53e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	4.09e-06	2.5e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	4.07e-06	2.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	4.06e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	4.06e-06	2.48e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	4.04e-06	2.47e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	4.02e-06	2.46e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.02e-06	2.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—pancreatic cancer	4.01e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.99e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SRC—pancreatic cancer	3.99e-06	2.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	3.98e-06	2.43e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	3.98e-06	2.43e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	3.97e-06	2.43e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	3.92e-06	2.4e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	3.91e-06	2.39e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	3.91e-06	2.39e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	3.89e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	3.88e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—pancreatic cancer	3.88e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—pancreatic cancer	3.88e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SRC—pancreatic cancer	3.86e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SRC—pancreatic cancer	3.86e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	3.85e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	3.84e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—pancreatic cancer	3.83e-06	2.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	3.83e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	3.76e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	3.76e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	3.73e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	3.72e-06	2.28e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	3.72e-06	2.28e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—pancreatic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—pancreatic cancer	3.71e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.67e-06	2.25e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.65e-06	2.24e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	3.65e-06	2.23e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.64e-06	2.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—pancreatic cancer	3.63e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.63e-06	2.22e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	3.62e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.6e-06	2.2e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	3.59e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—pancreatic cancer	3.57e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.57e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	3.57e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—pancreatic cancer	3.54e-06	2.17e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	3.54e-06	2.16e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	3.53e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—pancreatic cancer	3.51e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—pancreatic cancer	3.51e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.5e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	3.5e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—pancreatic cancer	3.46e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—pancreatic cancer	3.46e-06	2.11e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	3.46e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	3.45e-06	2.11e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	3.44e-06	2.1e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	3.44e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—pancreatic cancer	3.42e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—pancreatic cancer	3.42e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	3.38e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	3.38e-06	2.07e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	3.38e-06	2.07e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	3.37e-06	2.06e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.33e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	3.3e-06	2.02e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.25e-06	1.99e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.22e-06	1.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	3.19e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	3.19e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.19e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.16e-06	1.93e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.11e-06	1.9e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.08e-06	1.88e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.05e-06	1.86e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.03e-06	1.86e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	3.03e-06	1.86e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.99e-06	1.83e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.98e-06	1.82e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—pancreatic cancer	2.96e-06	1.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—pancreatic cancer	2.94e-06	1.8e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.93e-06	1.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.93e-06	1.8e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—pancreatic cancer	2.87e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—pancreatic cancer	2.87e-06	1.75e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—pancreatic cancer	2.84e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—pancreatic cancer	2.84e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.82e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	2.81e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.78e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.75e-06	1.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	2.72e-06	1.66e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	1.59e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.58e-06	1.58e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.57e-06	1.57e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	2.48e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.4e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	2.4e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	2.4e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.3e-06	1.41e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.2e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.12e-06	1.29e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.1e-06	1.28e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.69e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.38e-06	8.47e-06	CbGpPWpGaD
